Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Gleevec (Imatinib Mesylate) Capsules
Company:  Novartis Pharmaceuticals Corporation
Application No.:  21-335/S4
Approval Date: 12/20/2002


Date created: July 08, 2003

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.